NEW YORK (GenomeWeb) – Germany's Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission.

The deal creates a science sector giant that will "cover every step of the biotech production chain," Merck said in a statement. The company will have around 50,000 employees in 67 countries, working at 72 manufacturing sites worldwide, with combined pro forma full-year life science sales of €4.6 billion in 2014 and expected sales between €12.6 billion and €12.8 billion in 2015.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.